Guanoliquin KPD la C, Juca DCS, Alcocer YP, Cuadrado SPA. Modulation of the gut-brain axis through selective inhibition of the sodium-glucose cotransporter type 1: physiological and therapeutic implications. Int J Res Med Sci [Internet]. 2026 Jun. 29 [cited 2026 Jun. 30];14(7):3009-16. Available from: https://www.msjonline.org/index.php/ijrms/article/view/16735